Biography

Prof. James Michael Mathis

Tarleton State University, USA


Email: [email protected]


Qualifications

2011 M.H.A., Health Admin, Louisiana State University in Shreveport

1987 Ph.D., Univ. of Texas Southwestern Medical Center, Biochemistry

1982 B.S., Texas A M University, Chemistry


Publications (Selected)

  1. Pires, I. C., Shuchi, S. I., Tostes, B. D. V., Santos, D. K. D. N., Burnett, W. L., Leonce, B. C., ... & Mathis, J. M. (2024). Theranostics using MCM-41-based mesoporous silica nanoparticles: integrating magnetic resonance imaging and novel chemotherapy for breast cancer treatment. International Journal of Molecular Sciences, 25(15), 8097.
  2. Debnath, D., Nazzal, S., Acharya, S., Souza, H. D. D. S., Filho, P. F. D. A., Fudala, R., & Mathis, J. M. (2021). Using mesoporous silica nanoparticles (MSNs) for delivering the mesoionic compound MIH 2.4 Bl in treating breast cancer. Cancer Research, 81(13_Supplement), 1232-1232.
  3. O’Bryan, S. M., & Mathis, J. M. (2021). CXCL12 retargeting of an oncolytic adenovirus vector to the chemokine CXCR4 and CXCR7 receptors in breast cancer. Journal of cancer therapy, 12(6), 311.
  4. Petty, R., Sabnis, N., Debnath, D., Mathis, J., Zhang, J., Lacko, A., & Fudala, R. (2021). Developing a stable drug delivery system for the mesoionic compound MIH 2.4 Bl using reconstituted high-density lipoproteins (rHDL) nanoparticles.
  5. de Mascena Costa, L. A., Debnath, D., Harmon, A. C., de Sousa Araújo, S., da Silva Souza, H. D., de Athayde Filho, P. F., ... & Mathis, J. M. (2020). Mechanistic studies of cytotoxic activity of the mesoionic compound MIH 2.4 Bl in MCF-7 breast cancer cells. Oncology letters, 20(3), 2291-2301.
  6. Viana, R. D. S., Costa, L. A. D. M., Harmon, A. C., Gomes Filho, M. A., Falcão, E. H., Vicente, M. G., ... & Mathis, J. M. (2020). 177Lu-Labeled Eu-doped mesoporous SiO2 nanoparticles as a theranostic radiopharmaceutical for colorectal cancer. ACS Applied Nano Materials, 3(9), 8691-8701.
  7. Amaral de Mascena Costa, L., Harmon, A. C., Aguiar Coelho Teixeira, A., Cássio Silva de Lima, F., de Sousa Araújo, S., Del Piero, F., ... & Mathis, J. M. (2020). Cytotoxic activity of the mesoionic compound MIH 2.4 Bl in Breast Cancer Cell Lines. Breast cancer: basic and clinical research, 14, 1178223420913330.
  8. Filgueiras de Athayde Filho, P., Alves Junior, S., & de Mascena Diniz Maia, M. (2020). Cytotoxic Activity of the Mesoionic Compound MIH 2.4 Bl in Breast Cancer Cell Lines. Breast Cancer, 14(1178223420913330).
  9. Chen, M., Perez, R. L., Du, P., Bhattarai, N., McDonough, K. C., Ravula, S., ... & Warner, I. M. (2019). Tumor-targeting NIRF NanoGUMBOS with cyclodextrin-enhanced chemo/photothermal antitumor activities. ACS applied materials & interfaces, 11(31), 27548-27557.
  10. Kaufman, N. E., Meng, Q., Griffin, K. E., Singh, S. S., Dahal, A., Zhou, Z., ... & Vicente, M. G. H. (2019). Synthesis, characterization, and evaluation of near-IR boron dipyrromethene bioconjugates for labeling of adenocarcinomas by selectively targeting the epidermal growth factor receptor. Journal of medicinal chemistry, 62(7), 3323-3335.
  11. O'Bryan, S. M., & Mathis, J. M. (2018). Oncolytic virotherapy for breast cancer treatment. Current Gene Therapy, 18(4), 192-205.
  12. Bhattarai, N., Mathis, J. M., Chen, M., Perez, R. L., Siraj, N., Magut, P. K., ... & Warner, I. M. (2018). Endocytic selective toxicity of rhodamine 6G nanoGUMBOS in breast cancer cells. Molecular pharmaceutics, 15(9), 3837-3845.
  13. Costa, L. A. D. M., Lima, F. C. S. D., Viana, R. D. S., Araujo, S. D. S., Wischral, A., Souza, H. D. D. S., ... & Mathis, J. M. (2018). Antitumor activity of the mesoionic compound MI H 2.4 on breast cancer cell lines. Cancer Research, 78(13_Supplement), 5877-5877.
  14. Sasanuma, S., Ohtsuka, K., Kudo, S. E., Ogata, N., Maeda, Y., Misawa, M., ... & Ishida, F. (2018). Narrow band imaging efficiency in evaluation of mucosal healing/relapse of ulcerative colitis. Endoscopy international open, 6(05), E518-E523.
  15. Hidrovo, I., Dey, J., Chesal, M. E., Shumilov, D., Bhusal, N., & Mathis, J. M. (2017). Experimental method and statistical analysis to fit tumor growth model using SPECT/CT imaging: a preclinical study. Quantitative Imaging in Medicine and Surgery, 7(3), 299.


Profile Details

WoS ResearcherID: J-1379-2018

https://orcid.org/0000-0001-5528-5195

https://www.linkedin.com/in/michael-mathis-0b73338/

https://scholar.google.com/citations?user=T_Ujl2MAAAAJ&hl=en

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top